BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 29246530)

  • 21. [Current treatment of rheumatoid arthritis].
    Carli P; Landais C; Aletti M; Cournac JM; Poisnel E; Paris JF
    Rev Med Interne; 2009 Dec; 30(12):1067-79. PubMed ID: 19833415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The supplementary therapeutic DMARD role of low-dose glucocorticoids in rheumatoid arthritis.
    Cutolo M; Spies CM; Buttgereit F; Paolino S; Pizzorni C
    Arthritis Res Ther; 2014 Nov; 16 Suppl 2(Suppl 2):S1. PubMed ID: 25608624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Glucocorticoids on the Clinical and Radiographic Efficacy of Tofacitinib in Patients with Rheumatoid Arthritis: A Posthoc Analysis of Data from 6 Phase III Studies.
    Charles-Schoeman C; van der Heijde D; Burmester GR; Nash P; Zerbini CAF; Connell CA; Fan H; Kwok K; Bananis E; Fleischmann R
    J Rheumatol; 2018 Feb; 45(2):177-187. PubMed ID: 29142036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disease-modifying anti-rheumatic drug therapy and structural damage in early rheumatoid arthritis.
    Mullan RH; Bresnihan B
    Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S158-64. PubMed ID: 14969069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low dose glucocorticoids in early rheumatoid arthritis.
    Strand V; Simon LS
    Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S186-90. PubMed ID: 14969074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modern treatment strategies in rheumatoid arthritis.
    Hetland ML
    Dan Med Bull; 2011 Nov; 58(11):B4320. PubMed ID: 22047935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intra-articular glucocorticoid injections should not be neglected in the remission targeted treatment of early rheumatoid arthritis: a post hoc analysis from the NEO-RACo trial.
    Kuusalo LA; Puolakka KT; Kautiainen H; Alasaarela EM; Hannonen PJ; Julkunen HA; Kaipiainen-Seppänen OA; Korpela MM; Möttönen TT; Paimela LH; Peltomaa RL; Yli-Kerttula TK; Leirisalo-Repo M; Rantalaiho VM;
    Clin Exp Rheumatol; 2016; 34(6):1038-1044. PubMed ID: 27494516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination therapy in early rheumatoid arthritis.
    Gossec L; Dougados M
    Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S174-8. PubMed ID: 14969072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Glucocorticoid therapy in rheumatoid arthritis - pro].
    Pongratz G
    Dtsch Med Wochenschr; 2016 Oct; 141(22):1650. PubMed ID: 27824423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Benefits and risks of glucocorticoid therapy for the treatment of rheumatoid arthritis and management of glucocorticoid-induced osteoporosis].
    Suzuki Y; Wakabayashi T; Saito E; Yamada C; Suwa A
    Clin Calcium; 2009 Mar; 19(3):404-15. PubMed ID: 19252251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current evidence for the management of rheumatoid arthritis with glucocorticoids: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis.
    Gorter SL; Bijlsma JW; Cutolo M; Gomez-Reino J; Kouloumas M; Smolen JS; Landewé R
    Ann Rheum Dis; 2010 Jun; 69(6):1010-4. PubMed ID: 20448288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of very early rheumatoid arthritis with symptomatic therapy, disease-modifying antirheumatic drugs, or biologic agents: a cost-effectiveness analysis.
    Finckh A; Bansback N; Marra CA; Anis AH; Michaud K; Lubin S; White M; Sizto S; Liang MH
    Ann Intern Med; 2009 Nov; 151(9):612-21. PubMed ID: 19884622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maintenance of remission with combination etanercept-DMARD therapy versus DMARDs alone in active rheumatoid arthritis: results of an international treat-to-target study conducted in regions with limited biologic access.
    Pavelka K; Akkoç N; Al-Maini M; Zerbini CAF; Karateev DE; Nasonov EL; Rahman MU; Pedersen R; Dinh A; Shen Q; Vasilescu R; Kotak S; Mahgoub E; Vlahos B
    Rheumatol Int; 2017 Sep; 37(9):1469-1479. PubMed ID: 28597306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Micro-structural bone changes in early rheumatoid arthritis persist over 1-year despite use of disease modifying anti-rheumatic drug therapy.
    Feehan LM; Li LL; McKay HA
    BMC Musculoskelet Disord; 2017 Dec; 18(1):521. PubMed ID: 29228959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-dose prednisolone in rheumatoid arthritis: adverse effects of various disease modifying antirheumatic drugs.
    Malysheva OA; Wahle M; Wagner U; Pierer M; Arnold S; Häntzschel H; Baerwald CG
    J Rheumatol; 2008 Jun; 35(6):979-85. PubMed ID: 18412314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A dose of only 5 mg prednisolone daily retards radiographic progression in early rheumatoid arthritis - the Low-Dose Prednisolone Trial.
    Wassenberg S; Rau R; Zeidler H;
    Clin Exp Rheumatol; 2011; 29(5 Suppl 68):S68-72. PubMed ID: 22018187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).
    Furst DE; Schiff MH; Fleischmann RM; Strand V; Birbara CA; Compagnone D; Fischkoff SA; Chartash EK
    J Rheumatol; 2003 Dec; 30(12):2563-71. PubMed ID: 14719195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic markers of clinical remission in early rheumatoid arthritis after two years of DMARDs in a clinical setting.
    Vázquez I; Graell E; Gratacós J; Cañete JD; Viñas O; Ercilla MG; Gómez A; Hernández MV; Rodríguez-Cros JR; Larrosa M; Sanmartí R
    Clin Exp Rheumatol; 2007; 25(2):231-8. PubMed ID: 17543147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of conventional disease-modifying anti-rheumatic drugs in established RA.
    Jurgens MS; Jacobs JW; Bijlsma JW
    Best Pract Res Clin Rheumatol; 2011 Aug; 25(4):523-33. PubMed ID: 22137922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Periarticular and generalised bone loss in patients with early rheumatoid arthritis: influence of alendronate and intra-articular glucocorticoid treatment. Post hoc analyses from the CIMESTRA trial.
    Jensen TW; Hansen MS; Hørslev-Petersen K; Hyldstrup L; Abrahamsen B; Langdahl B; Zerahn B; Pødenphant J; Stengaard-Petersen K; Junker P; Østergaard M; Lottenburger T; Ellingsen T; Andersen LS; Hansen I; Skjødt H; Pedersen JK; Lauridsen UB; Svendsen AJ; Tarp U; Lindegaard H; Jurik AG; Vestergaard A; Hetland ML;
    Ann Rheum Dis; 2014 Jun; 73(6):1123-9. PubMed ID: 23661492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.